GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Altimmune Inc (STU:3G0) » Definitions » Cyclically Adjusted PS Ratio

Altimmune (STU:3G0) Cyclically Adjusted PS Ratio : (As of Jun. 05, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Altimmune Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Altimmune Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Altimmune's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Altimmune Cyclically Adjusted PS Ratio Chart

Altimmune Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.18 0.19 0.50 0.56

Altimmune Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.11 0.56 -

Competitive Comparison of Altimmune's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Altimmune's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Altimmune's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Altimmune's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Altimmune's Cyclically Adjusted PS Ratio falls into.



Altimmune Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Altimmune's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Altimmune's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/131.7762*131.7762
=0.000

Current CPI (Mar. 2024) = 131.7762.

Altimmune Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 14.797 100.560 19.390
201409 3.792 100.428 4.976
201412 7.019 99.070 9.336
201503 30.667 99.621 40.566
201506 4.835 100.684 6.328
201509 4.813 100.392 6.318
201512 5.409 99.792 7.143
201603 4.200 100.470 5.509
201606 0.613 101.688 0.794
201609 0.017 101.861 0.022
201612 0.996 101.863 1.288
201703 0.022 102.862 0.028
201706 0.010 103.349 0.013
201709 0.044 104.136 0.056
201712 15.921 104.011 20.171
201803 3.223 105.290 4.034
201806 2.164 106.317 2.682
201809 1.709 106.507 2.114
201812 0.251 105.998 0.312
201903 0.276 107.251 0.339
201906 0.110 108.070 0.134
201909 0.040 108.329 0.049
201912 0.034 108.420 0.041
202003 0.133 108.902 0.161
202006 0.036 108.767 0.044
202009 0.075 109.815 0.090
202012 0.052 109.897 0.062
202103 0.018 111.754 0.021
202106 0.003 114.631 0.003
202109 0.003 115.734 0.003
202112 0.068 117.630 0.076
202203 0.001 121.301 0.001
202206 0.000 125.017 0.000
202209 0.000 125.227 0.000
202212 -0.002 125.222 -0.002
202303 0.000 127.348 0.000
202306 0.000 128.729 0.000
202309 0.006 129.860 0.006
202312 0.001 129.419 0.001
202403 0.000 131.776 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Altimmune  (STU:3G0) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Altimmune Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Altimmune's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Altimmune (STU:3G0) Business Description

Industry
Traded in Other Exchanges
Address
910 Clopper Road, Suite 201S, Gaithersburg, MD, USA, 20878
Altimmune Inc is engaged on developing treatments for obesity and liver diseases. The Company's pipeline includes next generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Altimmune (STU:3G0) Headlines

No Headlines